RK

Rajendraprasad Kasarapu

Active Director Director DIN 07651873
DIN 07651873 First appointment Nov 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value •••• Premium profile

About Rajendraprasad Kasarapu

Data last updated:

Rajendraprasad Kasarapu is a Director at Trimark Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Trimark Pharmaceuticals Private Limited reported revenue of ₹91.6 Lakh (FY 2024).

DIN 07651873
Primary Designation Director
Industry Trading
First Appointment 09 Nov 2016
Oldest Company Age 9 yrs
Largest company Trimark Pharmaceuticals Private Limited · ₹91.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20162016₹91.6 Lakh (FY 2024)Active

Board colleagues of Rajendraprasad Kasarapu

Directorship timeline

Open interactive timeline →
Trimark Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajendraprasad Kasarapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendraprasad Kasarapu

Rajendraprasad Kasarapu currently holds 1 directorship: Trimark Pharmaceuticals Private Limited (Director, since 09 Nov 2016, revenue ₹91.6 Lakh (FY 2024)).

Rajendraprasad Kasarapu was first appointed on 09 Nov 2016 as Director at Trimark Pharmaceuticals Private Limited.

The current boards of Rajendraprasad Kasarapu's companies include Pavan Kumar Dubba (Trimark Pharmaceuticals Private Limited), Pranitha Kasarapu (Trimark Pharmaceuticals Private Limited), Uday Kumar Akula (Trimark Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available